amfAR Announces First Grants for COVID-19 Research
We are pleased to announce our first two research grants awarded through the amfAR Fund to Fight COVID-19. One grant will support a study of the acute kidney injury that can be a deadly consequence of advanced COVID-19 disease. The other one will support a study of antibody responses to COVID-19. You can read about the grants here.
Expanding our efforts to include research on the deadly new coronavirus, in April we established the amfAR Fund to Fight COVID-19. The fact is, amfAR is uniquely positioned to participate in the all-out effort to develop effective treatments and a vaccine for the coronavirus. However, we remain fully committed to HIV research and to finding a cure for the 38 million people worldwide living with HIV. All money donated for HIV research will stay in HIV research, whereas all donations to this special fund will be earmarked for research on COVID-19. In these challenging times, we are especially grateful for your generous support.
Frequently Asked Questions.
COVID-19 and HIV/AIDS
WHAT ARE THE COVID RISKS FOR PEOPLE LIVING WITH HIV?
When COVID-19 first emerged, there were good reasons to imagine that people living with HIV (PWH) might be at either increased, or decreased, risk due to their HIV infection or its treatment. What was needed were facts, so amfAR’s Vice President and Director of Research Dr. Rowena Johnston set out to analyze the outcomes in every reported case during the first six months of the pandemic.
READ FULL ARTICLE
CONNECTIONS: COVID-19 AND HIV
In this new video interview series, we speak with people living with HIV about their experience of COVID-19.
Steven Angelides of Boston, MA, was infected with the coronavirus, along with his partner and his cat. He discusses the experience and the echoes of the early days of HIV/AIDS.
Watch now on YouTube.
INTERSECTIONS: HIV AND COVID-19
In this series of short videos, Dr. Rowena Johnston, amfAR VP and Director of Research, talks to HIV researchers about their involvement in the fight against COVID-19. We’ll be adding new interviews regularly so check this page often.